Sudden cardiac arrest may be treated via attempts at
resuscitation. This is usually carried out based on
basic life support,
advanced cardiac life support (ACLS),
pediatric advanced life support (PALS), or
neonatal resuscitation program (NRP) guidelines.
Cardiopulmonary resuscitation Early
cardiopulmonary resuscitation (CPR) is essential to surviving cardiac arrest with good neurological function. It is recommended that it be started as soon as possible with minimal interruptions once begun. The components of CPR that make the greatest difference in survival are
chest compressions and defibrillating shockable rhythms. After defibrillation, chest compressions should be continued for two minutes before another rhythm check. It is unclear if a few minutes of CPR before defibrillation results in different outcomes than immediate defibrillation. Correctly performed bystander CPR has been shown to increase survival, however it is performed in fewer than 30% of out-of-hospital cardiac arrests (OHCAs) . Likewise, a 2022 systematic review on exercise-related cardiac arrests supported early intervention of bystander CPR and AED use (for shockable rhythms) as they improve survival outcomes. If high-quality CPR has not resulted in return of spontaneous circulation and the person's heart rhythm is in
asystole, stopping CPR and pronouncing the person's death is generally reasonable after 20 minutes. Some of these cases should have longer and more sustained CPR until they are nearly
normothermic. If this occurs, then modification to existing oropharyngeal suction may be required, such as using
suction-assisted airway management.
Tracheal intubation has not been found to improve survival rates or neurological outcomes in cardiac arrest, and in the prehospital environment, may worsen it. Endotracheal tubes and
supraglottic airways appear equally useful. When done by emergency medical personnel, 30 compressions followed by two breaths appear to be better than continuous chest compressions and breaths being given while compressions are ongoing.
Defibrillation Defibrillation is indicated if a shockable rhythm is present; the two shockable rhythms are
ventricular fibrillation and
ventricular tachycardia. These shockable rhythms have a 25-40% likelihood of survival, compared with a significantly lower rate (less than 5%) in non-shockable rhythms. The non-shockable rhythms include
asystole and pulseless electrical activity. Ventricular fibrillation involves the
ventricles of the heart rapidly contracting in an disorganized pattern, and thereby limiting blood flow from the heart. This is due to an uncoordinated electrical activity. The electrocardiogram (ECG) shows irregular QRS complexes at a very high rate (>300 beats per minute). In ventricular tachycardia, the ECG will show a wide complex rhythm at a rate higher than 100 beats per minute. These two rhythm lead to hemodynamic instability and compromise, resulting in poor perfusion to vital organs (including the heart itself). A defibrillator — either implanted or external — delivers an electrical current that results in the entire myocardium simultaneously depolarized thereby stopping the arrhythmia. Defibrillators can deliver energy as monophasic or biphasic waveforms, although biphasic defibrillators are now the most common. Prior studies suggest that biphasic shock is more likely to produce successful defibrillation after a single shock, however rate of survival is comparable between the methods. There is increasing use of public access to defibrillators. This typically involves placing AEDs in publicly-accessible places and training staff in these areas on how to use them. This allows defibrillation to occur prior to the arrival of emergency services, which has been shown to increase the chances of survival. People who have cardiac arrests in remote locations have worse outcomes. Defibrillation cannot reverse asystole or pulseless electrical activity, and CPR must be initiated first in these cases. A similar concept,
cardioversion, utilizes the same defibrillation machine but is used for other rhythms such as
atrial fibrillation and
supraventricular tachycardia. In these rhythms, the machine is "synchronized" to the QRS complex to avoid shocking on the T wave (and inducing VT or VF). Cardioversion can be done electively for rhythm control, or urgently if the rhythm is unstable.
Medications Medications recommended in the ACLS protocol include
epinephrine,
amiodarone, and
lidocaine. Epinephrine in adults improves survival but does not appear to improve neurologically normal survival. In ventricular fibrillation and pulseless ventricular tachycardia, 1 mg of epinephrine is given every 3–5 minutes, following an initial round of CPR and defibrillation. Amiodarone and lidocaine are anti-arrhythmic medications. Amiodarone is a
class III antiarrhythmic. Amiodarone may be used in cases of
ventricular fibrillation,
ventricular tachycardia, and
wide complex tachycardia. Lidocaine is a
Class IB anti-arrhythmic, also used to manage acute arrhythmias. Anti-arrhythmic medications may be used after an unsuccessful defibrillation attempt. However, neither lidocaine nor amiodarone improves survival to hospital discharge, despite both equally improving survival to hospital admission. The first dose is given as a 300 mg bolus. The second dose is given as a 600 mg bolus.
Calcium, given as calcium chloride, works as an
inotrope and
vasopressor. Calcium is used in specific circumstances such as electrolyte disturbances (hyperkalemia) and
calcium-channel blocker toxicity. Overall, calcium is not routinely used during cardiac arrest as it does not provide additional benefit (compared to non-use) and may even cause harm (poor neurologic outcomes).
Vasopressin overall does not improve or worsen outcomes compared to epinephrine. The use of atropine, lidocaine, and amiodarone have not been shown to improve survival from cardiac arrest. Calcium levels are considered a key factor contributing to cardiac arrests in this population.
Tricyclic antidepressant (TCA) overdose can lead to cardiac arrest with typical ECG findings including wide QRS and prolonged QTc. Treatment for this condition includes
activated charcoal and sodium bicarbonate. Magnesium can be given at a dose of 2 g (iv or oral bolus) to manage
torsades de points. However, without specific indication, magnesium is not generally given in cardiac arrest. In people with a confirmed
pulmonary embolism as the cause of arrest,
thrombolytics may be of benefit. The process involves cooling for a 24-hour period, with a target temperature of , followed by gradual rewarming over the next 12 to 24 hrs. There are several methods used to lower the body temperature, such as applying ice packs or cold-water circulating pads directly to the body or infusing cold saline. The effectiveness of TTM after OHCA is an area of ongoing study. Several recent reviews have found that patients treated with TTM have more favorable neurological outcomes.
Osborn waves on
ECG are frequent during TTM, particularly in patients treated with 33 °C.
Osborn waves are not associated with increased risk of ventricular arrhythmia, and may be considered a benign physiological phenomenon, associated with lower mortality in univariable analyses. Other directives may be made to stipulate the desire for
intubation in the event of
respiratory failure or, if comfort measures are all that are desired, by stipulating that healthcare providers should "allow natural death".
Chain of survival Several organizations promote the idea of a
chain of survival. The chain consists of the following "links": • Early recognition. If possible, recognition of illness before the person develops a cardiac arrest will allow the rescuer to prevent its occurrence. Early recognition that a cardiac arrest has occurred is key to survival, for every minute a patient stays in cardiac arrest, their chances of survival drop by roughly 10%. If one or more links in the chain are missing or delayed, then the chances of survival drop significantly. These protocols are often initiated by a
code blue, which usually denotes impending or acute onset of cardiac arrest or
respiratory failure.
Other Resuscitation with
extracorporeal membrane oxygenation devices has been attempted with better results for in-hospital cardiac arrest (29% survival) than OHCA (4% survival) in populations selected to benefit most.
Cardiac catheterization in those who have survived an OHCA appears to improve outcomes, although high-quality evidence is lacking. It is recommended to be done as soon as possible in those who have had a cardiac arrest with
ST elevation due to underlying heart problems. ==Prognosis==